Antibiotic pharmacists in the ascendancy

Journal of Antimicrobial Chemotherapy

Volumn 60, Issue SUPPL. 1, 2007, Pages

  Hand, Kieran ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Antimicrobial prescribing; Hospital; Microbiology; Pharmacy

Indexed keywords

ANTIINFECTIVE AGENT;

COMMUNICABLE DISEASE; HOSPITAL; HUMAN; PHARMACIST; REVIEW; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; COMMUNICABLE DISEASES; HOSPITALS; HUMANS; PHARMACISTS; TREATMENT OUTCOME;

EID: 34548781539     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm163     Document Type: Article

References (39)

1. Department of Health 2000. Pharmacy in the Future- Implementing the NHS Plan. London: UK Department of Health. www.dh.gov.uk/assetRoot/04/06/82/04/04068204.pdf (13 March 2007, date last accessed).
2. Schumock GT, Butler MG, Meek PD et al. Evidence of the economic benefit of clinical pharmacy services: 1996-2000. Pharmacotherapy 2003; 23: 113-32.
3. Bond CA, Raehl CL, Franke T. Interrelationships among mortality rates, drug costs, total cost of care, and length of stay in United States hospitals: summary and recommendations for clinical pharmacy services and staffing. Pharmacotherapy 2001; 21: 129-41.
4. Borja-Lopetegi A, Webb DG, Bates I et al. Association between clinical medicines management services, pharmacy workforce and patient outcomes. In: Abstracts of the UKCPA Progress in Practice Symposium, Leicestershire, UK, 2006. Short Paper Contributions, pp.16-17.
5. Department of Health (UK) 2005. Adult Critical Care: Specialist Pharmacy Practice. www.dh.gov.uk/assetRoot/04/11/40/93/04114093.pdf (13 March 2007, date last accessed).
6. Chief Medical Officer 2002. Getting Ahead of the Curve: A Strategy for Combating Infectious Diseases. www.dh.gov.uk/assetRoot/04/06/08/75/04060875.pdf (13 March 2007, date last accessed).
7. Chief Medical Officer 2003. Winning ways: Working Together to Reduce Healthcare Associated Infection in England. www.dh.gov.uk/ assetRoot/04/06/46/89/04064689.pdfdh.gov.uk/assetRoot/04/06/46/89/04064689.pdf (13 March 2007, date last accessed).
8. Standing Medical Advisory Committee Sub-group on Antimicrobial Resistance 1998. The Path of Least Resistance. www.advisorybodies.doh.gov.uk/smac1.htm (13 March 2007, date last accessed).
9. World Health Organization 2001. Global Strategy for Containment of Antimicrobial Resistance. www.who.int/drugresistance/WHO%20Global%20Strategy%20-%20Executive%20Summary%20-%20English%20version.pdf (13 March 2007, date last accessed)
10. Chief Medical Officer 2003. Hospital Pharmacy Initiative for Promoting Prudent Use of Antibiotics in Hospital. www.dh.gov.uk/assetRoot/04/01/35/63/04013563.pdf (13 March 2007, date last accessed)
11. Interdepartmental Steering Group on Resistance to Antibiotics and Other Antimicrobial Agents. Clinical Prescribing Subgroup 2001. Optimising the Clinical Use of Antimicrobials. wwww.dh.gov.uk/assetRoot/04/08/43/95/04084395.pdf (13 March 2007, date last accessed).
12. Wickens HJ, Jacklin A. Impact of the hospital pharmacy initiative for promoting prudent use of antibiotics in hospitals in England. J Antimicrob Chemother 2006; 58: 1230-7.
13. Hand K, Lawson W. A career as a specialist microbiology pharmacist. Hosp Pharm 2004; 11: 459-64.
14. Hand K. Education-the fundamental role of the antibiotic pharmacist. Pharm Prac 2004; 14: S3-S7.
15. Jepson A, Wickens HJ. What does a microbiology pharmacist do? Pharm J 2003; 271: 774-5.
16. Knox K, Lawson W, Dean B et al. Multidisciplinary antimicrobial management and the role of the infectious diseases pharmacist-a UK perspective. J Hosp Infect 2003; 53: 85-90.
17. Weller TM, Jamieson CE. The expanding role of the antibiotic pharmacist. J Antimicrob Chemother 2004; 54: 295-8.
18. Wickens HJ, Wade P. How pharmacists can promote the sensible use of antimicrobials. Pharm J 2004; 274: 427-30.
19. Lawson W, Ridge K, Jacklin A et al. Infectious diseases pharmacists in the UK: promoting their role establishing a national network. J Inf 2000; 40: A31.
20. British Society for Antimicrobial Chemotherapy. Hospital antibiotic control measures in the UK. J Antimicrob Chemother 1994; 34: 21-42.
21. Woodford EM, Wilson KA, Marriott JF. Documentation of antibiotic prescribing controls in UK NHS hospitals. J Antimicrob Chemother 2004; 53: 650-2.
22. Cabana MD, Rand CS, Powe NR et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999; 282: 1458-65.
23. Hayward RS, Guyatt GH, Moore KA et al. Canadian physicians' attitudes about and preferences regarding clinical practice guidelines. CMAJ 1997; 156: 1715-23.
24. Bond CA, Raehl CL. Clinical and economic outcomes of pharmacist-managed aminoglycoside or vancomycin therapy. Am J Health Syst Pharm 2005; 62: 1596-605.
25. Dean B, Jacklin A, Rogers T et al. The use of serial point prevalence studies to investigate antiinfective prescribing. Int J Pharm Pract 2002; 10: 121-5.
26. Pelle B, Gilchrist M, Lawson W et al. Using defined daily doses to study the use of antibacterials in UK hospitals. Hosp Pharm 2006; 13: 133-6.
27. Arnold FW, McDonald LC, Smith RS et al. Improving antimicrobial use in the hospital setting by providing usage feedback to prescribing physicians. Infect Control Hosp Epidemiol 2006; 27: 378-82.
28. Davey P, Brown E, Fenelon L et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev 2005; CD003543.
29. Ramsay C, Brown E, Hartman G et al. Room for improvement: a systematic review of the quality of evaluations of interventions to improve hospital antibiotic prescribing. J Antimicrob Chemother 2003; 52: 764-71.
30. Al-Eidan FA, McElnay JC, Scott MG et al. Use of a treatment protocol in the management of community-acquired lower respiratory tract infection. J Antimicrob Chemother 2000; 45: 387-94.
31. Dean NC, Silver MP, Bateman KA et al. Decreased mortality after implementation of a treatment guideline for community-acquired pneumonia. Am J Med 2001; 110: 451-7.
32. Carling P, Fung T, Killion A et al. Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years. Infect Control Hosp Epidemiol 2003; 24: 699-706.
33. Ansari F, Gray K, Nathwani D et al. Outcomes of an intervention to improve hospital antibiotic prescribing: interrupted time series with segmented regression analysis. J Antimicrob Chemother 2003; 52: 842-8.
34. Jones D, Cheesbrough J. Antibiotic pharmacist saves £10 per patient per day. HSJ 2005; 115: 30.
35. Wickens HJ, Robson R, Griffiths T. A web-based pharmacy to microbiology referral system. Hosp Pharm 2006; 13: 131-2.
36. Hills TJ, Boswell TC, Weston VC. The introduction and impact of an hypertext markup language-based antibiotic guidelines website. In: Abstracts of the UKCPA Progress in Practice Symposium, Leicestershire, UK, November 2006. Short Paper Contributions, pp.26-27.
37. Weeks C, Jones G, Wyllie S. Costs and health care benefits of an antimicrobial management programme. Hosp Pharm 2006; 13: 179-82.
38. Dellit TH, Owens RC, McGowan JE, Jr et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007; 44: 159-77.
39. Evans RS, Pestotnik SL, Classen DC et al. A computer-assisted management program for antibiotics and other antiinfective agents. N Engl J Med 1998; 338: 232-8.